The fund will normally invest at least 90% of its net assets (including investment borrowings) in the common stocks and depositary receipts that comprise the index. The index is an equal-dollar weighted index designed to measure the performance of a cross section of small, mid and large capitalization companies in the biotechnology industry that are primarily involved in the use of biological proc… read more
-
ETF
Equity
- years
31 holdings
$184.65
Price+2.99%
$5.36
$3.850b
Mid
$25.317k
Avg Volume$1.160b
$164.98
NAV0.56%
Expense Ratio0.63%
Yield$1.17
Dividend